Officer Sells $1.96M in BioLife Solutions Stock Amid 52-Week Lows
BLFS is trading near its 52-week low of $19.1 (4.2% above the low).
Summary
BioLife Solutions' Chief Quality and Operations Officer, Karen A. Foster, sold approximately $1.96 million worth of company stock in open market transactions, occurring as the stock trades near its 52-week low.
Key Events · Ownership and Investor Activity · BLFS
-
Officer Sells Significant Stake
Karen A. Foster, Chief Quality and Operations Officer, sold 97,423 shares of BioLife Solutions common stock for a total value of $1,962,998.
-
Sales Occur Near 52-Week Low
The transactions took place between March 5 and March 9, 2026, with prices ranging from $20.00 to $20.15 per share, while the company's stock is trading near its 52-week low of $19.10.
-
Post-Transaction Holdings
Following these sales, Ms. Foster directly holds 113,242 shares of BioLife Solutions.
Analysis · BLFS · Industrial Applications And Services
Karen A. Foster, the Chief Quality and Operations Officer, executed a substantial open market sale of BioLife Solutions stock, disposing of nearly $2 million worth of shares. This transaction occurred while the company's stock is trading near its 52-week low, which could be interpreted as a lack of confidence from a key executive. This insider selling contrasts with the recent positive financial results and investor presentation released by the company, potentially raising questions about the executive's outlook despite the reported strong performance.
At the time of this filing, BLFS was trading at $19.90 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $961.2M. The 52-week trading range was $19.10 to $29.62. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.